FDA Extends Safety Review of Mifepristone Abortion Pill to Next Year
The Food and Drug Administration said its ongoing safety review of the abortion pill mifepristone will continue into next year, with a final update expected around March, following a federal judge's order in a Louisiana lawsuit seeking to overturn the mail-delivery provision.
5outlets
6articles
17 hoursrunning
Oct 7first seen
Coverage over time
Articles
| Oct 8, 11:38 AM | azmirror.com | FDA says its abortion pill review will finish in December, and it’s report will be due by March |
| Oct 8, 7:03 AM | thefederalist.com | FDA Says It Won’t Act On Abortion Drugs Till March, 2 Years After Pledging To Review Safety Concerns |
| Oct 8, 3:30 AM | cbsnews.com | FDA says its abortion pill safety review will continue into next year |
| Oct 8, 12:14 AM | abcnews.com | FDA says its review of abortion pill will continue into next year |
| Oct 8, 12:14 AM | abcnews.com | FDA says its safety review of abortion pill will continue into next year |
| Oct 7, 6:29 PM | nbcnews.com | FDA says it will complete safety review of abortion pill in March |